Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
12 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 27(5); October 2011
Prev issue Next issue
Editorials
Is There Any Relationship between the Chronicity of Chronic Anal Fissure and Endothelin-1?
Won-Kyung Kang
J Korean Soc Coloproctol. 2011;27(5):221-221.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.221
  • 2,383 View
  • 31 Download
PDF
The Synchronous Prevalence of Colorectal Neoplasms in Patients with Stomach Cancer
Ryung Ah Lee
J Korean Soc Coloproctol. 2011;27(5):222-223.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.222
  • 2,460 View
  • 30 Download
PDF
Lymph Node Ratio for Nodal Staging in Colorectal Cancer - a Promising, but Premature Tool
Kang Young Lee
J Korean Soc Coloproctol. 2011;27(5):224-225.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.224
  • 2,368 View
  • 13 Download
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • CD169 identifies an activated CD8+T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients
    Jiali Zhang, Jing Xu, Rong-xin Zhang, Yi Zhang, Qing-jian Ou, Jin-qing Li, Ze-zhou Jiang, Xiao-jun Wu, Yu-jing Fang, Limin Zheng
    OncoImmunology.2016; 5(7): e1177690.     CrossRef
  • Impact of nodal ratio on survival in recurrent nasopharyngeal carcinoma
    Richie Chiu‐Lung Chan, Jimmy Yu Wai Chan
    Head & Neck.2015; 37(1): 12.     CrossRef
Review
Colorectal Cancer with Multiple Metastases: Is Palliative Surgery Needed?
Hong-Jo Choi, Jin Yong Shin
J Korean Soc Coloproctol. 2011;27(5):226-230.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.226
  • 2,908 View
  • 31 Download
  • 1 Citations
AbstractAbstract PDF

In patients with symptomatic incurable metastatic colorectal cancer (mCRC), the goal of resection of the primary lesion is to palliate cancer-related morbidity, including obstruction, bleeding, or perforation. In patients with asymptomatic primary tumors and incurable metastatic disease, however, the necessity of primary tumor resection is less clear. Although several retrospective analyses suggest survival benefit in patients who undergo resection of the primary tumor, applying this older evidence to modern patients is out of date for several reasons. Modern chemotherapy regimens incorporating the novel cytotoxic agents oxaliplatin and irinotecan, as well as the target agents bevacizumab and cetuximab, have improved median survival from less than 1 year with the only available single-agent 5-fluorouracil until the mid-1990s to over 2 years. In addition to significant prolongation of overall survival, combinations of novel chemotherapeutic and target agents have allowed improved local and distant tumor control, decreasing the likelihood of local tumor-related complications requiring surgical resection. Resection of an asymptomatic primary tumor risks surgical complications and may postpone the administration of chemotherapy that may offer both systemic and local control. In conclusion, the morbidity and the mortality of unnecessary surgery or surgery that does not improve quality of life or survival in patients with mCRC of a limited life expectancy should be carefully evaluated. With the availability of effective combinations of chemotherapy and target agents, systemic therapy for the treatment of life-threatening metastases would be a preferable treatment strategy for unresectable asymptomatic patients with mCRC.

Citations

Citations to this article as recorded by  
  • Palliative laparoscopic bowel resection in stage IV colorectal cancer patients with unresectable metastasis
    Kwan Mo Yang, Seok-Byung Lim, Yong Sik Yoon, Chan Wook Kim, In Ja Park, Chang Sik Yu, Jin Cheon Kim
    Korean Journal of Clinical Oncology.2013; 9(2): 134.     CrossRef
Original Articles
Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer
Nam Won Kim, Chong Woo Chu, Tae Sung Ahn, Chang Jin Kim, Dong Jun Jung, Myoung Won Son, Sang Ho Bae, Moon Soo Lee, Chang Ho Kim, Moo Jun Baek
J Korean Soc Coloproctol. 2011;27(5):231-236.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.231
  • 3,808 View
  • 28 Download
  • 5 Citations
AbstractAbstract PDF
Purpose

Phosphatase of regenerating liver-3 (PRL-3) has been associated with metastasis promotion. However, clinical applications of this association have not yet been clearly demonstrated. In this study, we evaluated the relation of PRL-3 mRNA level in primary colorectal cancer to the corresponding stage and to other clinicopathologic factors.

Methods

Two hundred forty-five patients with histologically-proven colorectal cancer underwent surgery between January 2004 and December 2006. RNA was extracted and cDNA was prepared by using reverse transcription. Quantification of PRL-3 was done using a real-time polymerase chain reaction.

Results

Eighty-six cases with well-preserved specimens were enrolled: 53 males and 33 females. The mean age was 63.4 years. According to tumour node metastasis (TNM) stage of the American Joint Committee on Cancer (AJCC), stage I was 11 cases, stage II was 38 cases, stage III was 23 cases, and stage IV was 14 cases. Among stage IV cases, one case was combined with liver and lung metastases, and one case was combined with liver metastases and peritoneal dissemination. The remaining stage IV patients were combined with only liver metastases. There was a significant correlation in PRL-3 mRNA expression between primary colorectal cancer and corresponding tumor stage. PRL-3 mRNA expression was increased in the liver metastases cases. Lymphatic and vascular invasion were significantly related with PRL-3 mRNA levels.

Conclusion

Advanced stage prediction may be obtained by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Especially, the risk of liver metastases may be predicted by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Further study is required to confirm these preliminary results.

Citations

Citations to this article as recorded by  
  • Colorectal liver metastasis: molecular mechanism and interventional therapy
    Hui Zhou, Zhongtao Liu, Yongxiang Wang, Xiaoyong Wen, Eric H. Amador, Liqin Yuan, Xin Ran, Li Xiong, Yuping Ran, Wei Chen, Yu Wen
    Signal Transduction and Targeted Therapy.2022;[Epub]     CrossRef
  • A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer
    Chuanyuan Liu, Wu Zhong, Laiyang Xia, Chuanfa Fang, Hongquan Liu, Xiaochun Liu
    Medicine.2021; 100(17): e25658.     CrossRef
  • Physiological and oncogenic roles of the PRL phosphatases
    Serge Hardy, Elie Kostantin, Teri Hatzihristidis, Yevgen Zolotarov, Noriko Uetani, Michel L. Tremblay
    The FEBS Journal.2018; 285(21): 3886.     CrossRef
  • Biomarkers for predicting future metastasis of human gastrointestinal tumors
    Lui Ng, Ronnie Tung Ping Poon, Roberta Pang
    Cellular and Molecular Life Sciences.2013; 70(19): 3631.     CrossRef
  • Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion
    James J. Fiordalisi, Brian J. Dewar, Lee M. Graves, James P. Madigan, Adrienne D. Cox, Jung Weon Lee
    PLoS ONE.2013; 8(5): e64309.     CrossRef
Is There Any Relationship between the Chronicity of Chronic Anal Fissure and Endothelin-1?
Cheong Ho Lim, Hyeon Keun Shin, Wook Ho Kang, Seung Kyu Jeong, Hyung Kyu Yang
J Korean Soc Coloproctol. 2011;27(5):237-240.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.237
  • 3,014 View
  • 33 Download
  • 3 Citations
AbstractAbstract PDF
Purpose

Many kinds of substances are produced on vascular endothelial activation. The aim of this study is to confirm an increase in Endothelin-1 (ET-1), the most potent vasoconstrictor, which is produced by endothelial activation, in patients with chronic anal fissure and to infer the relationship between ET-1 and anal fissure chronicity.

Methods

The study groups are divided into three different groups with 30 subjects each. Group 1 is comprised of healthy volunteers, group 2 of chronic anal fissure patients, and Group 3 of patients with higher than 3rd degree hemorrhoids. Blood samples were taken to measure the ET-1 levels in subject's serum and to compare the results with those for the control groups.

Results

Among the 90 subjects, 38 were male, and 52 were female. The average age was 36.8. The average ET-1 level marked 1.47 ± 0.78 pg/mL for male subjects and 1.16 ± 0.47 pg/mL for female subjects (P = 0.02). The average ET-1 level in the patient groups is as follow: 1.21 ± 0.44 pg/mL in group 1, 1.46 ± 0.83 pg/mL in group 2, and 1.20 ± 0.56 pg/mL in group 3 (P = 0.14).

Conclusion

Group 2, the chronic anal fissure patient group, showed a higher ET-1 level than groups 1 and 3, the control group and the hemorrhoid patient group, but this difference had no statistical significance.

Citations

Citations to this article as recorded by  
  • Impact of Anal Fissure on Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness: A Case-Control Study
    Paloma Luri-Prieto, Asunción Candela-Gomis, Antonio Palazón-Bru, Felipe Navarro-Cremades, Vicente Francisco Gil-Guillén, Antonio Fernando Compañ-Rosique
    Visceral Medicine.2021; 37(2): 128.     CrossRef
  • Anatomie und Pathogenese der Analfissur
    Martin Mitteregger
    coloproctology.2020; 42(6): 441.     CrossRef
  • Cost considerations in the treatment of anal fissures
    Giuseppe Brisinda, Giuseppe Bianco, Nicola Silvestrini, Giorgio Maria
    Expert Review of Pharmacoeconomics & Outcomes Research.2014; 14(4): 511.     CrossRef
Laparoscopic Versus Open Appendectomy for Appendicitis in Elderly Patients
Hyun Nam Baek, Yong Hwan Jung, Yong Hee Hwang
J Korean Soc Coloproctol. 2011;27(5):241-245.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.241
  • 4,291 View
  • 50 Download
  • 12 Citations
AbstractAbstract PDF
Purpose

The appendectomy is the most common emergent surgical procedure in elderly patients. The increasing number of elderly persons has been accompanied by an increase in the number of cases of acute appendicitis in the elderly. In order to understand the clinical significance of a laparoscopic appendectomy for elderly patients with appendicitis, we investigated the results of a laparoscopic appendectomy for treating patients over 60 years of age with appendicitis and compared them with the results for an open technique.

Methods

We studied retrospectively patients over 60 years of age who underwent an appendectomy with either a laparoscopic (LA) or open (OA) technique for appendicitis between July 2007 and December 2009. There were 30 patients in the LA group and 47 patients in the OA group. The demographic data, operative time, length of the hospital stay, bowel movement, pain control, cost, complications and pre-existing disease were assessed.

Results

There were no significant differences between the LA and the OA groups with respect to pre-existing diseases, gender, age, American Society of Anesthesiologists (ASA) score and the number of cases of complicated appendicitis, operative time, length of hospital stay, and times of analgesics use. However, the proportion of early gas out (within POD #2) was significantly greater in the LA group (80% vs. 57%, P < 0.05), and postoperative complications were significantly lower in the LA group (7% vs. 32%, P < 0.01). The costs for the two groups were not significantly different.

Conclusion

A laparoscopic appendectomy is a safe and effective procedure in elderly patients and is not associated with any increase in morbidity. It can be recommended for routine use in treating elderly patients with appendicitis.

Citations

Citations to this article as recorded by  
  • EAES/SAGES evidence-based recommendations and expert consensus on optimization of perioperative care in older adults
    Deborah S. Keller, Nathan Curtis, Holly Ann Burt, Carlo Alberto Ammirati, Amelia T. Collings, Hiram C. Polk, Francesco Maria Carrano, Stavros A. Antoniou, Nader Hanna, Laure-Meline Piotet, Sarah Hill, Anne C. M. Cuijpers, Patricia Tejedor, Marco Milone, E
    Surgical Endoscopy.2024; 38(8): 4104.     CrossRef
  • Laparoscopic and robotic surgery for colorectal cancer in older patients: a systematic review and meta-analysis
    Carlo Alberto Ammirati, Roberto Passera, Elsa Beltrami, Chiara Peluso, Nader Francis, Alberto Arezzo
    Minimally Invasive Therapy & Allied Technologies.2024; 33(5): 253.     CrossRef
  • The Role of Basic Laboratory Parameters in Diagnosing Acute Appendicitis and Determining Disease Severity in the Elderly
    Mustafa Yeni, Rıfat Peksöz
    Turkish Journal of Colorectal Disease.2022; 32(2): 110.     CrossRef
  • Comparison of Postoperative Acute Kidney Injury Between Laparoscopic and Laparotomy Procedures in Elderly Patients Undergoing Colorectal Surgery
    Shun Huang, Zheng Li, Nan Zou, Ting Dai, Xiang Long Cao, Zhe Jia, Wen Ping Peng, Ning Yang, Rui Fang Jia, Ming Zhang Zuo
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2021; 31(2): 160.     CrossRef
  • GERİATRİK AKUT APANDİSİTLERİN TANI VE TEDAVİSİNDEKİ FARKLILIKLAR: TEK MERKEZ DENEYİMİ
    Ahmet TÜRKAN, Ahmet ERDOĞAN, Uğur KILINÇ
    Kırıkkale Üniversitesi Tıp Fakültesi Dergisi.2021; 23(1): 1.     CrossRef
  • Acute Appendicitis in the Elderly: A Literature Review on an Increasingly Frequent Surgical Problem
    Sintija Lapsa, Arturs Ozolins, Ilze Strumfa, Janis Gardovskis
    Geriatrics.2021; 6(3): 93.     CrossRef
  • Perforated vs. nonperforated acute appendicitis: evaluation of short-term surgical outcomes in an elderly population
    Fabio Rondelli, Michele De Rosa, Paolo Stella, Marcello Boni, Graziano Ceccarelli, Ruben Balzarotti, Andrea Polistena, Alessandro Sanguinetti, Walter Bugiantella, Nicola Avenia
    Minerva Chirurgica.2019;[Epub]     CrossRef
  • Outcomes of appendectomy in elderly veteran patients
    Oswaldo Renteria, Zain Shahid, Sergio Huerta
    Surgery.2018; 164(3): 460.     CrossRef
  • Independent Preoperative Predictors of Prolonged Length of Stay after Laparoscopic Appendectomy in Patients over 30 Years of Age: Experience from a Single Institution
    Eric S. Wise, Stephen P. Gadomski, Annette M. Ilg, Camilo Bermudez, Emily W. Chan, Michelle L. Izmaylov, Samantha J. Gridley, Jessica V. Kaczmarek, Norman T. Melancon, Sarwat Ahmad, Kyle M. Hocking, Jose J. Diaz, Stephen M. Kavic
    The American Surgeon™.2016; 82(11): 1092.     CrossRef
  • Conventional Laparoscopic Appendicectomy and Laparoscope-Assisted Appendicectomy: a Comparative Study
    Mayank Baid, Manoranjan Kar, Utpal De, Mrityunjay Mukhopadhyay
    Indian Journal of Surgery.2015; 77(S2): 330.     CrossRef
  • Acute appendicitis: position paper, WSES, 2013
    Ferdinando Agresta, Luca Ansaloni, Fausto Catena, Luca Andrea Verza, Daniela Prando
    World Journal of Emergency Surgery.2014;[Epub]     CrossRef
  • Thirty-day outcomes of laparoscopic versus open appendectomy in elderly using ACS/NSQIP database
    Ashkan Moazzez, Rodney J. Mason, Namir Katkhouda
    Surgical Endoscopy.2013; 27(4): 1061.     CrossRef
The Synchronous Prevalence of Colorectal Neoplasms in Patients with Stomach Cancer
Sang Su Lee, Woon Tae Jung, Cha Young Kim, Chang Yoon Ha, Hyun Ju Min, Hyun Jin Kim, Tae Hyo Kim
J Korean Soc Coloproctol. 2011;27(5):246-251.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.246
  • 3,548 View
  • 29 Download
  • 9 Citations
AbstractAbstract PDF
Purpose

The association between stomach cancer and colorectal cancer is controversial. The purpose of this study was to determine the synchronous prevalence of colorectal neoplasms in patients with stomach cancer.

Methods

A total of 123 patients with stomach cancer (86 male) and 246 consecutive, age- and sex-matched persons without stomach cancer were analyzed from July 2005 to June 2010. All of them underwent colonoscopy within 6 months after undergoing gastroscopy.

Results

The prevalence of colorectal neoplasms was significantly higher in the stomach cancer group (35.8%) than in the control group (17.9%) (P < 0.001). Colorectal neoplasms were more prevalent in the patients with stomach cancer (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.71 to 5.63). In particular, the difference in the prevalence of colorectal neoplasms was more prominent in the patients above 50 years old (OR, 3.54; 95% CI, 1.80 to 6.98).

Conclusion

The results showed that the synchronous prevalence of colorectal neoplasms was higher in patients with stomach cancer than in those without stomach cancer. Therefore, patients with stomach cancer should be regarded as a high-risk group for colorectal neoplasms, and colonoscopy should be recommended for screening.

Citations

Citations to this article as recorded by  
  • Colonoscopy plays an important role in detecting colorectal neoplasms in patients with gastric neoplasms
    Xu-Rui Liu, Ze-Lin Wen, Fei Liu, Zi-Wei Li, Xiao-Yu Liu, Wei Zhang, Dong Peng
    World Journal of Gastrointestinal Oncology.2024; 16(1): 133.     CrossRef
  • Retrospective cohort study investigating association between precancerous gastric lesions and colorectal neoplasm risk
    Hui Pan, Yu-Long Zhang, Chao-Ying Fang, Yu-Dai Chen, Li-Ping He, Xiao-Ling Zheng, Xiaowen Li
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Genetic analyses supporting colorectal, gastric, and prostate cancer syndromes
    Karin Wallander, Wen Liu, Susanna von Holst, Jessada Thutkawkorapin, Vinaykumar Kontham, Anna Forsberg, Annika Lindblom, Kristina Lagerstedt‐Robinson
    Genes, Chromosomes and Cancer.2019; 58(11): 775.     CrossRef
  • Frequency and risk factors of colorectal adenoma in patients with early gastric cancer
    Hyun H. Chung, Kyeong O. Kim, Si H. Lee, Byung I. Jang, Tae N. Kim
    Internal Medicine Journal.2017; 47(10): 1184.     CrossRef
  • Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer?
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Yoon Suk Jung
    Journal of Korean Medical Science.2017; 32(8): 1281.     CrossRef
  • Is Preoperative Work-Up Colonoscopy Necessary for Patient with Gastric Cancer?
    Hee Chan Yang, Ju Hyung Lee, Sung Kyun Yim, Hong-Seon Son, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(4): 215.     CrossRef
  • Short-term Outcomes of Laparoscopic Surgery for Synchronous Gastric and Colorectal Cancer
    Ryoji Makizumi, Shinya Mikami, Kuniyasu Horikoshi, Tsukasa Shimamura, Shinjiro Kobayashi, Akira Hanai, Satoshi Tsukikawa, Yukihito Kokuba, Nobuyoshi Miyajima, Takehito Otsubo
    Journal of St. Marianna University.2015; 6(2): 273.     CrossRef
  • Clinical Significance of Colonoscopy in Patients with Upper Gastrointestinal Polyps and Neoplasms: A Meta-Analysis
    Zhen-Jie Wu, Yuan Lin, Jun Xiao, Liu-Cheng Wu, Jun-Gang Liu, John Green
    PLoS ONE.2014; 9(3): e91810.     CrossRef
  • Role of Preoperative Colonoscopy in Patients with Gastric Cancer: A Case Control Study of the Prevalence of Coexisting Colorectal Neoplasms
    Han Mo Yoo, Tae Geun Gweon, Ho Seok Seo, Jung Ho Shim, Sung Il Oh, Myung Gyu Choi, Kyo Young Song, Hae Myoung Jeon, Cho Hyun Park
    Annals of Surgical Oncology.2013; 20(5): 1614.     CrossRef
Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer
Jin Yong Shin, Kwan Hee Hong
J Korean Soc Coloproctol. 2011;27(5):252-259.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.252
  • 3,150 View
  • 27 Download
  • 7 Citations
AbstractAbstract PDF
Purpose

Although nodal metastasis is the most powerful prognostic factor in rectal cancer, marked heterogeneity exists within stage III rectal cancer. Recent studies of rectal cancer have shown a prognostic superiority of the lymph node ratio (LNR) compared with N stage. The purpose of this study was to investigate the prognostic value of the LNR in the era of the 7th edition of the TNM classification.

Methods

We included 190 patients who underwent a curative resection for rectal cancer with nodal metastasis. The patients were divided into four groups on the basis of statistically calculated cut-off values as 0.21, 0.32, and 0.61.

Results

The LNR was an independent risk factor for overall survival (OS; P = 0.008) and for systemic recurrence-free survival (SRFS; P = 0.002). However, the LNR was not a predictive factor for local recurrence. When the N stage of the sixth TNM staging system was separately analyzed as a covariate, the LNR was also found to be a predictive factor for both OS and SRFS (P = 0.012 and P = 0.004, respectively). A LNR value of 0.21 offered the best cut off to separate patients into two prognostic groups.

Conclusion

The defined cut-off values of the LNR were an independent risk factor for OS and distant metastasis-free survival in patients with rectal cancer, irrespective of the sixth or the seventh version of the TNM classification, and the LNR should be considered as a prognostic variable in any future staging system.

Citations

Citations to this article as recorded by  
  • Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis
    Jian Zhou, Zhangyu Lin, Mengyuan Lyu, Nan Chen, Hu Liao, Zihuai Wang, Jianqi Hao, Chunyi Yan, Lunxu Liu
    Japanese Journal of Clinical Oncology.2020; 50(1): 44.     CrossRef
  • Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival
    Richard Walker, Trevor Wood, Emily LeSouder, Michelle Cleghorn, Manjula Maganti, Andrea MacNeill, Fayez A. Quereshy
    Journal of Surgical Oncology.2018; 117(5): 1049.     CrossRef
  • The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer
    Chi-Hao Zhang, Yan-Yan Li, Qing-Wei Zhang, Alberto Biondi, Valeria Fico, Roberto Persiani, Xiao-Chun Ni, Meng Luo
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database
    Ben Huang, Chen Chen, Mengdong Ni, Shaobo Mo, Guoxiang Cai, Sanjun Cai
    International Journal of Surgery.2016; 32: 24.     CrossRef
  • Clinical Significance of the Metastatic Lymph-Node Ratio in Rectal Cancer
    Hyoung Chul Park
    Annals of Coloproctology.2013; 29(3): 89.     CrossRef
  • Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer
    Wafi Attaallah, Omer Gunal, Manuk Manukyan, Gulden Ozden, Cumhur Yegen
    Annals of Coloproctology.2013; 29(3): 100.     CrossRef
  • O índice de linfonodos comprometidos como um preditor para a ocorrência de recidivas tumorais no câncer de cólon estádio III
    Tiago L. Dedavid e Silva, Daniel C. Damin
    Revista do Colégio Brasileiro de Cirurgiões.2013; 40(6): 463.     CrossRef
Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer
Yo Han Park, Jae Im Lee, Jong Kyung Park, Hang Ju Jo, Won Kyung Kang, Chang Hyeok An
J Korean Soc Coloproctol. 2011;27(5):260-265.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.260
  • 4,325 View
  • 28 Download
  • 8 Citations
AbstractAbstract PDF
Purpose

Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.

Methods

We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR. The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.

Results

There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7 (P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4 ≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.

Conclusions

LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.

Citations

Citations to this article as recorded by  
  • The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single‐institution cohort
    Hongdian Zhang, Wanyi Xiao, Peng Ren, Kai Zhu, Ran Jia, Yueyang Yang, Lei Gong, Zhentao Yu, Peng Tang
    Cancer Medicine.2021; 10(17): 6149.     CrossRef
  • Lymph Node Ratio and Liver Metachronous Metastases in Colorectal Cancer
    Giovanni Li Destri, Giuseppe Privitera, Gaetano La Greca, Roberto Scilletta, Antonio Pesce, Teresa Rosanna Portale, Erminia Conti, Stefano Puleo
    International Surgery.2021; 105(1-3): 122.     CrossRef
  • Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors
    Gianpiero Gravante, David Hemingway, James Andrew Stephenson, David Sharpe, Ahmed Osman, Melissa Haines, Vafa Pirjamali, Roberto Sorge, Justin Ming Yeung, Michael Norwood, Andrew Miller, Kirsten Boyle
    Journal of Surgical Oncology.2016; 114(5): 642.     CrossRef
  • Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer
    Wafi Attaallah, Omer Gunal, Manuk Manukyan, Gulden Ozden, Cumhur Yegen
    Annals of Coloproctology.2013; 29(3): 100.     CrossRef
  • Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
    Leila Ghahramani, Leila Moaddabshoar, Samira Razzaghi, Sayed Hasan Hamedi, Saeedeh Pourahmad, Mohammad Mohammadianpanah
    Annals of Colorectal Research.2013; 1(3): 81.     CrossRef
  • Prognostic Value of Lymph Node Ratios in Node Positive Rectal Cancer Treated with Preoperative Chemoradiation
    Jamal Jafari Nadoshan, Ramesh Omranipour, Omid Beiki, Kazem Zendedel, Abbas Alibakhshi, Habibollah Mahmoodzadeh
    Asian Pacific Journal of Cancer Prevention.2013; 14(6): 3769.     CrossRef
  • Proposal of a New Classification for Stage III Colorectal Cancer Based on the Number and Ratio of Metastatic Lymph Nodes
    Li‐Ping Wang, Hong‐Yan Wang, Rui Cao, Cong Zhu, Xiong‐Zhi Wu
    World Journal of Surgery.2013; 37(5): 1094.     CrossRef
  • An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all
    M. Medani, Niall Kelly, George Samaha, G. Duff, Vourneen Healy, Elizabeth Mulcahy, Eoghan Condon, David Waldron, Jean Saunders, J. Calvin Coffey
    International Journal of Colorectal Disease.2013; 28(10): 1377.     CrossRef
Case Reports
Oxaliplatin-induced Pulmonary Fibrosis: Two Case Reports
Chun-Geun Ryu, Eun-Joo Jung, Gangmi Kim, Su Ran Kim, Dae-Yong Hwang
J Korean Soc Coloproctol. 2011;27(5):266-269.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.266
  • 3,121 View
  • 28 Download
  • 7 Citations
AbstractAbstract PDF

Oxaliplatin with infusional 5-fluorouracil plus leucovorin (FOLFOX regimen) is the one of the standard chemotherapy regimens for treating a colorectal carcinoma. The most common side effects include neutropenia, diarrhea, vomiting and peripheral neuropathy, and these are moderate and manageable. However, pulmonary toxicity is rarely reported to be associated with the FOLFOX regimen. Moreover, there is no established guideline for the management of this side effect. Here, along with a literature review, we report two cases of rapidly developing pulmonary fibrosis related to the use of the FOLFOX regimen in patients with colorectal carcinomas.

Citations

Citations to this article as recorded by  
  • Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality
    Kinnera Sahithi Urlapu, Dmitry Lvovsky
    Cureus.2023;[Epub]     CrossRef
  • Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study and Literature Review
    Ana C. Moreira, João Portela, Carlos Couto, José Duarte, Natália Martins, Jorge Soares
    Oncology and Therapy.2020; 8(2): 183.     CrossRef
  • A case report of acute pulmonary hypertension after hyperthermic intraperitoneal chemotherapy (HIPEC) and review of the literature
    Thomas S. Zajonz, Michael Sander, Winfried Padberg, Andreas Hecker, Ruediger Hörbelt, Christian Koch, Emmanuel Schneck
    Annals of Medicine and Surgery.2018; 27: 26.     CrossRef
  • Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient
    Annick De Weerdt, Amélie Dendooven, Annemie Snoeckx, Jan Pen, Martin Lammens, Philippe G. Jorens
    BMC Cancer.2017;[Epub]     CrossRef
  • Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature
    Mor Moskovitz, Mira Wollner, Nissim Haim
    Case Reports in Oncological Medicine.2015; 2015: 1.     CrossRef
  • Pulmonary Fibrosis Secondary to FOLFOX Chemotherapy: A Case Report
    Wai Cheong Soon, Kate West, David Gibeon, Elizabeth Frances Bowen
    Case Reports in Oncology.2014; 7(3): 662.     CrossRef
  • Granulomatous Lung Disease Requiring Mechanical Ventilation Induced by a Single Application of Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Case Report
    Dane Wildner, Frank Boxberger, Axel Wein, Kerstin Wolff, Heinz Albrecht, Gudrun Männlein, Rolf Janka, Kerstin Amann, Jürgen Siebler, Werner Hohenberger, Markus F. Neurath, Richard Strauß
    Case Reports in Oncological Medicine.2013; 2013: 1.     CrossRef
Recurrent Renal Leiomyosarcoma Mimicking a Colonic Submucosal Tumor: A Case Report
Yun Jeung Kim, Hee Seok Moon, Eaum Seok Lee, Jae Kyu Sung, Hyun Yong Jeong, Ji Yeon Kim, Dae Young Kang
J Korean Soc Coloproctol. 2011;27(5):270-274.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.270
  • 3,097 View
  • 32 Download
  • 1 Citations
AbstractAbstract PDF

A primary leiomyosarcoma of the kidney is a rare, but highly aggressive, neoplasm, accounting for only 0.1% of all invasive renal tumors. Local or systemic recurrence is common, but a leiomyosarcoma is difficult to diagnose preoperatively. We recently encountered an interesting case of an unusual recurrence of a renal leiomyosarcoma. A 57-year-old woman visited our hospital complaining of lower abdominal pain. Four years previously, she had undergone a left nephrectomy. She had a primary leiomyosarcoma of the kidney that had been misdiagnosed as a renal cell carcinoma. Colonoscopy revealed the presence of a lesion similar to a submucosal tumor in the descending colon. Postoperative pathologic examination confirmed that the mass was a recurrent leiomyosarcoma. We report this unusual case and present a review of the literature.

Citations

Citations to this article as recorded by  
  • A Rare Case of Colonic Leiomyosarcoma in Association with Ulcerative Colitis
    Daisuke Akutsu, Yuji Mizokami, Hideo Suzuki, Masahiko Terasaki, Toshiaki Narasaka, Tsuyoshi Kaneko, Hirofumi Matsui, Tsuyoshi Enomoto, Taiki Sato, Ichinosuke Hyodo
    Internal Medicine.2016; 55(19): 2799.     CrossRef

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP